Literature DB >> 32110142

Restless Legs Syndrome in Patients with Behçet's Disease and Multiple Sclerosis: Prevalence, Associated Conditions and Clinical Features.

Ayşenur Önalan1, Zeliha Matur1, Münevver Pehlıvan1, Gülşen Akman1.   

Abstract

INTRODUCTION: To investigate the prevalence and characteristics of Restless Legs Syndrome (RLS) in patients with Behçet's Disease (BD) and Multiple Sclerosis (MS).
METHODS: Consecutive patients with BD and MS seen in the outpatient clinic were included in the study. As a control group, volunteer subjects without a known peripheral or central nervous system disorder were included. The BD group was divided into two sub-groups as BD with neurological involvement [Neuro-Behçet's Disease (NBD)] and BD without any neurological involvement (other BD) for further evaluation. Data on demographic characteristics, medical history and family history were collected, and all patients underwent neurological examination. The patients were evaluated for the presence of diagnostic criteria for RLS. The features and severity of RLS were evaluated in patients with RLS using Restless Legs Syndrome Identification Form, and the International Restless Legs Syndrome Study Group (IRLSSG) Rating Scale. The clinical and radiological findings of patients with BD and MS were retrieved from their medical files.
RESULTS: The study included a total of 96 patients with BD (mean age 39.9±11.8; 51 males; 41 patients with NBD) and 97 patients with MS (mean age 34.97±4.1 years; 24 males). There were 100 healthy control subjects (mean age 36.18±11.10 years; 46 males). RLS was more prevalent in MS (22.8%) and NBD (22%) groups compared to the control group (10%; p=0.004 and 0.029, respectively) with a statistically significant difference. The prevalence of RLS was higher in MS patients with less disability. Most severe RLS symptoms were observed in the MS group. The rate of sleep disorders was also higher in MS group. Although stress appeared to be a factor worsening RLS in all groups, its prevalence was higher in the MS group (p=0.011). There was no correlation between the distribution of magnetic resonance imaging lesions and RLS in both MS and NBD groups.
CONCLUSIONS: It is well established that RLS can accompany disorders involving the peripheral and central nervous systems such as all types of peripheral neuropathy, myelopathy, and Parkinson's disease. The present study showed that MS and NBD also seem to be a risk factor for RLS, being associated with more severe symptoms. Copyright:
© 2020 Turkish Neuropsychiatric Society.

Entities:  

Keywords:  Behçet’s disease; Restless legs syndrome; multiple sclerosis; neuro-Behçet’s disease

Year:  2018        PMID: 32110142      PMCID: PMC7024827          DOI: 10.5152/npa.2017.20562

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  29 in total

1.  New multiple sclerosis phenotypic classification.

Authors:  Fred D Lublin
Journal:  Eur Neurol       Date:  2014-09-26       Impact factor: 1.710

2.  Restless legs syndrome in multiple sclerosis.

Authors:  Gülay Aydar; Semiha Kurt; Hatice Karaer Unaldi; Unal Erkorkmaz
Journal:  Eur Neurol       Date:  2011-05-13       Impact factor: 1.710

3.  Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study.

Authors:  J Vávrová; D Kemlink; K Sonka; E Havrdová; D Horáková; B Pardini; B Müller-Myhsok; J Winkelmann
Journal:  Sleep Med       Date:  2012-05-19       Impact factor: 3.492

4.  Topography of the sensations in primary restless legs syndrome.

Authors:  Elias Georges Karroum; Smaranda Leu-Semenescu; Isabelle Arnulf
Journal:  J Neurol Sci       Date:  2012-06-15       Impact factor: 3.181

Review 5.  Restless legs syndrome in multiple sclerosis.

Authors:  Mariusz Sieminski; Jacek Losy; Markku Partinen
Journal:  Sleep Med Rev       Date:  2014-10-12       Impact factor: 11.609

Review 6.  Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

Authors:  Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi
Journal:  Sleep Med       Date:  2003-03       Impact factor: 3.492

7.  Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey.

Authors:  S Sevim; O Dogu; H Camdeviren; R Bugdayci; T Sasmaz; H Kaleagasi; M Aral; I Helvaci
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

Review 8.  An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment.

Authors:  Diego Garcia-Borreguero; Anne-Marie Williams
Journal:  Curr Opin Neurol       Date:  2014-08       Impact factor: 5.710

9.  Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.

Authors:  Juliane Winkelmann; Barbara Schormair; Peter Lichtner; Stephan Ripke; Lan Xiong; Shapour Jalilzadeh; Stephany Fulda; Benno Pütz; Gertrud Eckstein; Stephanie Hauk; Claudia Trenkwalder; Alexander Zimprich; Karin Stiasny-Kolster; Wolfgang Oertel; Cornelius G Bachmann; Walter Paulus; Ines Peglau; Ilonka Eisensehr; Jacques Montplaisir; Gustavo Turecki; Guy Rouleau; Christian Gieger; Thomas Illig; H-Erich Wichmann; Florian Holsboer; Bertram Müller-Myhsok; Thomas Meitinger
Journal:  Nat Genet       Date:  2007-07-18       Impact factor: 38.330

Review 10.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

View more
  1 in total

Review 1.  Sleep quality in Behçet's disease: a systematic literature review.

Authors:  N Italiano; F Di Cianni; D Marinello; E Elefante; M Mosca; R Talarico
Journal:  Rheumatol Int       Date:  2022-10-04       Impact factor: 3.580

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.